<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02064205</url>
  </required_header>
  <id_info>
    <org_study_id>JZ PDX Satiety</org_study_id>
    <secondary_id>WM-01-2014</secondary_id>
    <nct_id>NCT02064205</nct_id>
  </id_info>
  <brief_title>Appetite Suppression Trial With Polydextrose</brief_title>
  <official_title>A Double Blind, Placebo Controlled, Randomized, Cross-over Study to Assess the Effects of Polydextrose on Appetite Suppression and Its Mechanisms of Action in Healthy Women With a Normal Weight and Overweight Female Participants.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>W.J. Pasman</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TNO</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Overweight and obesity are a global epidemic, which causes a rapid increase in the frequency
      of diabetes and cardiovascular diseases. Food ingredients that influence the mechanisms that
      regulate satiety may play a role in weight management. Suppression of appetite may reduce
      energy intake, which in return may lead to body weight reduction. This study aims to verify
      the appetite suppressive effect of polydextrose in comparison to a placebo in normal weight
      and overweight women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Polydextrose is a well-tolerated, low calorie glucose polymer (4kJ/g) that can be easily
      incorporated into various food applications to replace sugar and fat (Auerbach et al., 2007).
      Polydextrose is poorly digested in the upper gastrointestinal tract and therefore shows
      fiber-like properties. The addition of polydextrose to foods may increase the satiating
      properties of foods.

      Previous studies have shown that:

        -  Consuming polydextrose-containing preloads (6.25 - 25.0 g polydextrose) resulted in a
           significant lower energy intake at lunch compared to the control (Astbury et al., 2013;
           Ranawana et al., 2013; Hull et al., 2012; King et al., 2005).

        -  Polydextrose is able to modify appetite ratings at low (6.25 - 12.5 g polydextrose)
           (Hull et al., 2012) and high doses (56.7 g/d) (Konings et al., 2013).

        -  Polydextrose (15.0 g) induced enhanced GLP-1 response after a high-fat meal in obese
           participants (Tiihonen et al., 2012).

      Therefore, it is hypothesized that with the consumption of 12.5 g polydextrose as compared
      with the placebo, appetite will be suppressed, resulting in:

        -  a lower consumption at lunch (energy intake at lunch)

        -  change in appetite scores (VAS)

        -  change in satiety hormones (CCK, PYY, GLP-1, ghrelin)

        -  change in glucose and insulin

        -  change in stomach emptying rate

        -  change in gastric wellbeing
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Breakfast meal with or without polydextrose</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Energy Intake at an ad Libitum Lunch on a Test-day in Normal Weight and Overweight Women.</measure>
    <time_frame>Four hours or 1.5 hour after consumption of a pre-load at up to day 22</time_frame>
    <description>Yogurt with a polydextrose (fiber with satiating effect) is consumed in the morning with breakfast or later in the morning. The satiating effect of the addition of polydextrose is tested on the amount of food consumed with lunch four hours or 1.5h later.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Appetite Suppressive Effect of Polydextrose During Meal Consumption (Satiation) and Satiety (After Food Consumption)</measure>
    <time_frame>one day</time_frame>
    <description>The appetite suppressive effect of polydextrose measured with Visual Analogue rating Scales (VAS). The AUCs were calculated for the scores obtained before - first score after meal intake (satiation) and for score after meal till start of next meal (in between meals, satiety). The VAS scores ranged from 0-100 for hunger and fullness (HUNGER: 0 = no hunger , 100 = very hungry; FULNESS: 0 = not full, 100 = very full)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate Effect of Pre-load on Satiety Hormones in Normal Weight and Overweight Women.</measure>
    <time_frame>Four hour curves (t=0, 30, 60, 90, 150 and 240 min) of day 01, day 08, day 15 and day 22.</time_frame>
    <description>The satiety hormones CCK, GLP-1, ghrelin and PYY are measured before (t=0) and after breakfast consumption (at t=30, 60, 90, 150, 240) . This is done on day 01, day 08, day 15 and day 22 with at least four days wash-out in-between.
The satiety hormones were only measured in the conditions when the pre-load was given with breakfast (condition A and B).
Area under the curves were calculated of the time curves.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Body Weight</condition>
  <condition>Non-restrained Eaters</condition>
  <arm_group>
    <arm_group_label>polydextrose or glucose syrup at breakfast</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Breakfast with pre-load four hours before lunch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pre-load with yogurt and polydextrose or glucose later</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Breakfast without pre-load. Pre-load with yogurt provided 1.5h before lunch.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>12.5 g polydextrose</intervention_name>
    <description>Appetite suppressing supplement is added in yogurt and provided with breakfast (four hours before lunch) or 1.5h before lunch. Also yogurt with control (glucose syrup) is tested for its satiating effect.</description>
    <arm_group_label>polydextrose or glucose syrup at breakfast</arm_group_label>
    <arm_group_label>Pre-load with yogurt and polydextrose or glucose later</arm_group_label>
    <other_name>LitesseÂ®Ultra TM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>glucose syrup</intervention_name>
    <description>Glucose syrup is used a control product for the polydextrose</description>
    <arm_group_label>polydextrose or glucose syrup at breakfast</arm_group_label>
    <arm_group_label>Pre-load with yogurt and polydextrose or glucose later</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy, female participants aged 20-45 years inclusive

          2. BMI: 20-30 kg/m2 inclusive

          3. Written consent regarding participation after full information regarding all details
             of the study

          4. Normal Dutch eating habits (consuming mostly three main meals per day; used to eat
             bread for lunch)

        Exclusion Criteria:

          1. Pregnancy

          2. On-going or recent treatment for diabetes, hypertension, coronary heart disease,
             psychiatric conditions, inflammatory chronic disease - rheumatoid arthritis, Crohn
             Disease, ulcerous colitis, chronic constipation, eating disorders, or any disease
             condition which interferes with ADME of the investigational product

          3. Reported postmenopausal

          4. Having menstruation problems, e.g. PCOS

          5. Reported to be on a slimming diet or other dietary treatment (currently or during last
             two months, like vegetarian diet, lactose restricted diet etc.)

          6. Aversion towards products (yoghurt) provided in the study

          7. On-going use of any slimming preparations

          8. Any kind of dysfunction of digestive tract, food allergy, chronic constipation,
             recent/actual gastroenteritis

          9. Restrained eaters (score DEBQ &gt;3.4)

         10. Participants consuming more than 23g of dietary fiber per day - P75 according to the
             Dutch National Food Consumption Survey - (as assessed with a general short
             questionnaire which gives estimation on the fiber intake. Exact fiber intake will not
             be calculated)

         11. Smoker in the last 3 months

         12. Heavy coffee drinkers (more than 6 cups a day)

         13. High level of physical activity: Participants who perform more than 3 hours of intense
             training/sport activity per week (this will not include normal cycling transport)

         14. Heavy alcohol consumers, no more than 14 units per week (1 unit represents 1 standard
             glass/portion of alcohol, independent of the type of alcoholic drink).

        Remark:

        When enough subjects are eligible (&gt; 32), the women with the highest BMI will be selected
        to participate. At least 50% of the subjects will have a BMI ranging of 25-30. Also at
        least 50% of the women will be in the age range of 25-45 years. When more than 32 subjects
        are eligible the eldest subjects will be included.

        With respect to eligibility of the subjects:

        the BMI criterion always comes for age criterion, meaning that overweight is stressed to be
        of more importance for this study than age. Overweight will always come first, even when
        already &gt; 50% of the women with a BMI 25-30 have been included. In this way the overweight
        group of women will be studied as much as possible.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naguib Muhsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>QPS, The Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>QPS</name>
      <address>
        <city>Groningen</city>
        <zip>9713AG</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2014</study_first_submitted>
  <study_first_submitted_qc>February 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2014</study_first_posted>
  <results_first_submitted>December 24, 2015</results_first_submitted>
  <results_first_submitted_qc>July 25, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 27, 2016</results_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>TNO</investigator_affiliation>
    <investigator_full_name>W.J. Pasman</investigator_full_name>
    <investigator_title>Project Manager Clinical Trials</investigator_title>
  </responsible_party>
  <keyword>pre-load</keyword>
  <keyword>satiety</keyword>
  <keyword>energy intake</keyword>
  <keyword>appetite</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment lasted from May 2014 - August 2014. 121 subjects were planned for screening. 46 subjects met the inclusion criteria, 37 subjects did not show up, and 38 subjects had screening failures.
The CRO that conducted the clinical trial was:
QPS Netherlands B.V. Groningen The Netherlands</recruitment_details>
      <pre_assignment_details>In the study four test days were conducted, one weekly. Between test day there are six days of wash-out.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>All Study Participants</title>
          <description>A: Breakfast with the pre-load and 12.5 g polydextrose B:Breakfast with the pre-load without polydextrose C: Breakfast and pre-load with 12.5 g polydextrose at 150 min D:Breakfast and pre-load without polydextrose at t=150 min
Eight orders:
A-B-D-C; B-C-A-D; C-D-B-A; D-A-C-B; A-D-B-C; C-B-D-A; B-A-C-D; D-C-A-B.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Condition A</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Condition B</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Condition C</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Condition D</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Baseline Charactistics of 32 Slightly Overweight Women</title>
          <description>Baseline data of the subjects were measured at screening at least one week before the start of the study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.4" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Netherlands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.4" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>meter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.70" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <description>Body Mass Index</description>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.9" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BPsys</title>
          <description>Systolic blood pressure</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="113.5" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BPdia</title>
          <description>Diastolic blood pressure</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.2" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Dutch Eating Restraintness Score</title>
          <description>Score ranges from 0 - 5 0 = unrestrained 5 = very restrained</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.4" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Dietary fiber intake</title>
          <units>grams/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Energy Intake at an ad Libitum Lunch on a Test-day in Normal Weight and Overweight Women.</title>
        <description>Yogurt with a polydextrose (fiber with satiating effect) is consumed in the morning with breakfast or later in the morning. The satiating effect of the addition of polydextrose is tested on the amount of food consumed with lunch four hours or 1.5h later.</description>
        <time_frame>Four hours or 1.5 hour after consumption of a pre-load at up to day 22</time_frame>
        <population>Energy intake</population>
        <group_list>
          <group group_id="O1">
            <title>Polydextrose Syrup at Breakfast [A]</title>
            <description>Breakfast with pre-load four hours before lunch
12.5 g polydextrose: Appetite suppressing supplement is added in yogurt and provided with breakfast, four hours before lunch.</description>
          </group>
          <group group_id="O2">
            <title>Glucose Syrup at Breakfast (Control) [B]</title>
            <description>Breakfast with control pre-load four hours before lunch
Yogurt with control (glucose syrup) is tested for its satiating effect.
glucose syrup: Glucose syrup is used a control product for the polydextrose</description>
          </group>
          <group group_id="O3">
            <title>Pre-load With Polydextroseglucose Before Lunch [C]</title>
            <description>Breakfast without pre-load. Pre-load with yogurt and polydextrose provided 1.5h before lunch.
12.5 g polydextrose: Appetite suppressing supplement is added in yogurt 1.5h before lunch.</description>
          </group>
          <group group_id="O4">
            <title>Pre-load With Yogurt and Glucose Before Lunch [D]</title>
            <description>Breakfast without pre-load. Pre-load with yogurt and glucose (control) provided 1.5h before lunch.
Yogurt with control (glucose syrup) is tested for its satiating effect 1.5h before lunch</description>
          </group>
        </group_list>
        <measure>
          <title>Energy Intake at an ad Libitum Lunch on a Test-day in Normal Weight and Overweight Women.</title>
          <description>Yogurt with a polydextrose (fiber with satiating effect) is consumed in the morning with breakfast or later in the morning. The satiating effect of the addition of polydextrose is tested on the amount of food consumed with lunch four hours or 1.5h later.</description>
          <population>Energy intake</population>
          <units>kJ</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
                <count group_id="O3" value="31"/>
                <count group_id="O4" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2694" spread="1028"/>
                    <measurement group_id="O2" value="2537" spread="933"/>
                    <measurement group_id="O3" value="2317" spread="940"/>
                    <measurement group_id="O4" value="2335" spread="1051"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>A mixed model was applied to analyze the Energy Intakes (ad libitum lunch and daily) were done one-sided to evaluate the appetite suppressive effect after the pre-load snack (condition C versus D)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.2918</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>18</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1000</dispersion_value>
            <ci_n_sides>1-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Appetite Suppressive Effect of Polydextrose During Meal Consumption (Satiation) and Satiety (After Food Consumption)</title>
        <description>The appetite suppressive effect of polydextrose measured with Visual Analogue rating Scales (VAS). The AUCs were calculated for the scores obtained before - first score after meal intake (satiation) and for score after meal till start of next meal (in between meals, satiety). The VAS scores ranged from 0-100 for hunger and fullness (HUNGER: 0 = no hunger , 100 = very hungry; FULNESS: 0 = not full, 100 = very full)</description>
        <time_frame>one day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Polydextrose Syrup Preload With Yogurt With Breakfast [A]</title>
            <description>Polydextrose syrup preload with yogurt with breakfast was consumed four hours before lunch</description>
          </group>
          <group group_id="O2">
            <title>Glucose Syrup as Proload With Breakfast (Control) [B]</title>
            <description>Breakfast with glucose syrup and yogurt provided four hours before lunch.</description>
          </group>
          <group group_id="O3">
            <title>Pre-load With Polydextrose Before Lunch [C]</title>
            <description>Pre-load with polydextrose syrup and yogurt is provided 1.5h before lunch</description>
          </group>
          <group group_id="O4">
            <title>Pre-load With Glucose Syrup Before Lunch [D]</title>
            <description>Pre-load with glucose syrup and yogurt was provided 1.5h before lunch.</description>
          </group>
        </group_list>
        <measure>
          <title>The Appetite Suppressive Effect of Polydextrose During Meal Consumption (Satiation) and Satiety (After Food Consumption)</title>
          <description>The appetite suppressive effect of polydextrose measured with Visual Analogue rating Scales (VAS). The AUCs were calculated for the scores obtained before - first score after meal intake (satiation) and for score after meal till start of next meal (in between meals, satiety). The VAS scores ranged from 0-100 for hunger and fullness (HUNGER: 0 = no hunger , 100 = very hungry; FULNESS: 0 = not full, 100 = very full)</description>
          <units>mm*min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="31"/>
                <count group_id="O4" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hunger score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="358.3" spread="183.4"/>
                    <measurement group_id="O2" value="336.8" spread="158.9"/>
                    <measurement group_id="O3" value="356.7" spread="169.1"/>
                    <measurement group_id="O4" value="280.2" spread="167.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fullness score during first phase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-424.7" spread="192.4"/>
                    <measurement group_id="O2" value="-443.0" spread="190.7"/>
                    <measurement group_id="O3" value="-326.6" spread="207.6"/>
                    <measurement group_id="O4" value="-308.2" spread="155.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hunger score (satiety period)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4898.9" spread="3424"/>
                    <measurement group_id="O2" value="4134.9" spread="2962.9"/>
                    <measurement group_id="O3" value="962.8" spread="1232.2"/>
                    <measurement group_id="O4" value="592.9" spread="987.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fulness score (satiety period)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6009.9" spread="3670.8"/>
                    <measurement group_id="O2" value="-5048.3" spread="4088.4"/>
                    <measurement group_id="O3" value="-734.8" spread="1263.5"/>
                    <measurement group_id="O4" value="-1077.4" spread="1118.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>AUC of hunger scores before preload intake for condition C versus D.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0109</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Evaluate Effect of Pre-load on Satiety Hormones in Normal Weight and Overweight Women.</title>
        <description>The satiety hormones CCK, GLP-1, ghrelin and PYY are measured before (t=0) and after breakfast consumption (at t=30, 60, 90, 150, 240) . This is done on day 01, day 08, day 15 and day 22 with at least four days wash-out in-between.
The satiety hormones were only measured in the conditions when the pre-load was given with breakfast (condition A and B).
Area under the curves were calculated of the time curves.</description>
        <time_frame>Four hour curves (t=0, 30, 60, 90, 150 and 240 min) of day 01, day 08, day 15 and day 22.</time_frame>
        <population>Only in condition A and B blood was drawn and satiety hormones were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Polydextrose Syrup at Breakfast [A]</title>
            <description>Breakfast with polydextrose and yogurt provided four hours before lunch.</description>
          </group>
          <group group_id="O2">
            <title>Glucose Syrup at Breakfast (Control) [B]</title>
            <description>Breakfast with glucose syrup and yogurt provided four hours before lunch.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluate Effect of Pre-load on Satiety Hormones in Normal Weight and Overweight Women.</title>
          <description>The satiety hormones CCK, GLP-1, ghrelin and PYY are measured before (t=0) and after breakfast consumption (at t=30, 60, 90, 150, 240) . This is done on day 01, day 08, day 15 and day 22 with at least four days wash-out in-between.
The satiety hormones were only measured in the conditions when the pre-load was given with breakfast (condition A and B).
Area under the curves were calculated of the time curves.</description>
          <population>Only in condition A and B blood was drawn and satiety hormones were analyzed.</population>
          <units>(mcg*min)/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CCK (AUC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="241.15" spread="113.69"/>
                    <measurement group_id="O2" value="265.03" spread="112.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ghrelin (AUC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-23479" spread="33428"/>
                    <measurement group_id="O2" value="-20902" spread="21150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PYY (AUC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1745.5" spread="2861.7"/>
                    <measurement group_id="O2" value="1210.5" spread="2832.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GLP-1 (AUC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="447.65" spread="298.11"/>
                    <measurement group_id="O2" value="316.02" spread="244.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A mixed model was applied to statistically analyze satiety hormones having Conditions and Time as a fixed factor and having Subject, Cohort, and Treatment Day as random factors.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0216</p_value>
            <p_value_desc>GLP-1</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During the conduct of the study; June - November 2014</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Condition A</title>
          <description>Breakfast with preload of yogurt and polydextrose</description>
        </group>
        <group group_id="E2">
          <title>Condition B</title>
          <description>Breakfast with preload of yogurt and glucose control</description>
        </group>
        <group group_id="E3">
          <title>Condition C</title>
          <description>Breakfast without preload; pre-load provided at t=150 min as a mid-morning snack of yogurt and polydextrose</description>
        </group>
        <group group_id="E4">
          <title>Condition D</title>
          <description>Breakfast without preload; pre-load provided at t=150 min as a mid-morning snack of yogurt and glucose syrup</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Vomitting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>catheter site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pyrexia (fever)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infections and infestations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Presyncope (light headedness)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Dysmenorrhea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>W.J. Pasman, PhD</name_or_title>
      <organization>TNO</organization>
      <phone>+31888665129</phone>
      <email>wilrike.pasman@tno.nl</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

